IGF-1LR3 (0.1mg / 1mg) appears in Growth Research catalogs for qualified buyers who need specification, COA, and RUO clarity—IGF-1LR3 COA and Batch Review Notes summarizes key checks.
IGF-1LR3 is a long-arginine analog of insulin-like growth factor 1 used in laboratory research on IGF-1 receptor signaling, protein analog behavior, cell-growth pathway models, and peptide structure-activity studies.
Muscle cell differentiation studies cite LR3 analogs when IGFBP interference must be minimized in serum-free experimental systems. IGF-1 LR3 contains an arginine substitution at position 3 and a 13-amino-acid extension reducing IGF-binding protein affinity, prolonging receptor engagement in cell culture.
Research examines PI3K–Akt and MAPK pathway phosphorylation time courses in myoblast and fibroblast lines treated with LR3 versus native IGF-1. Receptor autophosphorylation assays, cell proliferation curves, and apoptosis markers (cleaved caspase-3) are common endpoints.
Cross-check CAS 946870-92-4 and purity target ≥ 99.0%; archive approved PDFs with internal sample IDs. Janoshik records for IGF-1LR3, when listed at sulanpeptide.vip/coa, should be verified by task number and unique key before sample release.
COA review: Match COA product name, lot, test date, and HPLC purity to vial labels for IGF-1LR3.
Catalog identifiers for IGF-1LR3: CAS 946870-92-4, Formula: C400H625N111O115S9. MW Approx. 9.1 kDa, purity target ≥ 99.0%. Copy these fields into requisitions and match them line-by-line on incoming COA PDFs.
Request method details on IGF-1LR3 COA if purity is reported without chromatogram context.
Migration and receptor assays for IGF-1LR3 are sensitive to degradation—confirm lot purity before release.
Migration and signaling assays using IGF-1LR3 are sensitive to oxidized or aggregated peptide. Lot release should include visual inspection (White Lyophilized Powder) plus COA approval—not catalog marketing text alone. COA review for IGF-1LR3 starts with identity: product name, lot, and specification (0.1mg / 1mg) must match the vial label character-for-character. QA teams then confirm CAS 946870-92-4 and purity target ≥ 99.0% against internal release thresholds before material enters cell or animal workflows.
Chromatographic context on IGF-1LR3 COA documents matters when purity is near your laboratory cutoff. Request integration traces or method summary if the PDF lists only a numeric HPLC result without column or gradient details. Archive IGF-1LR3 COA PDFs using filenames tied to internal sample IDs (for example LAB-2026-0042_COA.pdf). Link reconstitution logs and aliquot records to the same ID chain so audits retrieve documentation in one step.
Janoshik-verified IGF-1LR3 batches listed at sulanpeptide.vip/coa add third-party confirmation when task number and unique key validate successfully. Failed verification should trigger quarantine until the supplier clarifies batch status.
Archive IGF-1LR3 COA PDFs using filenames tied to internal sample IDs (for example LAB-2026-0042_COA.pdf). Link reconstitution logs and aliquot records to the same ID chain so audits retrieve documentation in one step. Janoshik-verified IGF-1LR3 batches listed at sulanpeptide.vip/coa add third-party confirmation when task number and unique key validate successfully. Failed verification should trigger quarantine until the supplier clarifies batch status.
Chromatographic context on IGF-1LR3 COA documents matters when purity is near your laboratory cutoff. Request integration traces or method summary if the PDF lists only a numeric HPLC result without column or gradient details.
IGF-1LR3 from Sulan Peptide Official is for research use only (RUO)—not for human or veterinary use. Questions: Contact page or WhatsApp on sulanpeptide.vip.